10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 223 filers reported holding 10X GENOMICS INC in Q3 2020. The put-call ratio across all filers is 0.25 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,355 | -30.8% | 638,921 | -6.4% | 0.04% | -22.4% |
| Q2 2023 | $38,099 | -4.2% | 682,284 | -4.3% | 0.05% | -7.5% |
| Q1 2023 | $39,788 | +97.7% | 713,170 | +29.2% | 0.05% | +89.3% |
| Q4 2022 | $20,121 | -99.9% | 552,181 | -9.2% | 0.03% | +12.0% |
| Q3 2022 | $17,315,000 | -37.7% | 607,953 | -0.9% | 0.02% | -30.6% |
| Q2 2022 | $27,773,000 | +23.2% | 613,768 | +107.1% | 0.04% | +50.0% |
| Q1 2022 | $22,541,000 | -36.3% | 296,321 | +24.8% | 0.02% | -33.3% |
| Q4 2021 | $35,369,000 | +3.0% | 237,439 | +0.6% | 0.04% | -2.7% |
| Q3 2021 | $34,348,000 | -25.8% | 235,939 | -0.2% | 0.04% | -22.9% |
| Q2 2021 | $46,294,000 | +59.2% | 236,409 | +47.2% | 0.05% | +50.0% |
| Q1 2021 | $29,071,000 | +50.0% | 160,611 | +17.3% | 0.03% | +45.5% |
| Q4 2020 | $19,385,000 | +83.1% | 136,898 | +61.2% | 0.02% | +69.2% |
| Q3 2020 | $10,585,000 | +43.0% | 84,900 | +2.4% | 0.01% | +44.4% |
| Q2 2020 | $7,404,000 | – | 82,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |